This former Dividend King isn't out of the woods yet.

Despite Performance Declines Since Spinning Out of 3M, Trian Believes Solventum Has Potential to Drive Significant Improvements as a Standalone Company

A standalone Honeywell aerospace business could be worth up to $120 billion.

Trian Fund Management reshaped its portfolio in Q3. The moves come as Donald Trump's election victory is expected to bring significant economic policy shifts.

3M stock, Dow Jones Industrial Average component, flirted with a breakout on Tuesday morning after reporting better than expected earnings.

Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.

September may have a reputation, but investors can find opportunities for growth and value by focusing on solid fundamentals and business models.

Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations.

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps with their one-year price returns.

3M Company cut its dividend because of legal settlements, the divestment of the Healthcare segment into an independent company, Solventum, and the need to maintain financial flexibility. It is the third Dividend King to do so in 2024.

The uncertainty around 3M's business is starting to clear, but there are still problems here that must be considered.

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps with their one-year price returns.

Trian Fund Management, co-founded by billionaire Nelson Peltz, still owns a piece of Walt Disney Company after selling its entire stake in May.

SOLV stock results show that Solventum beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

These Dow stocks to watch have all been beaten down over the past year or more but are now poised for a rebound.

Earn dividends and participate in earnings growth with these blue-chip stocks that beat Q2 earnings and raised guidance.

3M's fall from grace is at an end, the stock rebound is gaining momentum after better-than-expected results that point to growth and distribution increases.

Adial Pharmaceuticals stock is up with heavy trading of ADIL after providing investors with an update on its AD04 clinical trial.